AzTrials
AzTrials

AstigmatismNCT01207466

Evaluation of Two Daily Disposable Contact Lenses for Wearers With Astigmatism

A study testing Nelfilcon A investigational contact lens and Nelfilcon A commercial contact lens in people with Astigmatism and Myopia, run by CIBA VISION.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this trial is to compare the performance of two contact lenses for contact lens wearers with astigmatism. Read more about this study

Who is it for?
Any age
Conditions the study is for
Astigmatism, Myopia
What is being tested?
Nelfilcon A investigational contact lens and Nelfilcon A commercial contact lens
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
95 participants
Where
No sites listed yet
Study dates
Sep 2010to Oct 2010
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Currently wearing soft contact lenses with astigmatism correction
  • Other protocol inclusion criteria may apply

Who cannot join

  • Eye injury or surgery within twelve weeks prior to enrollment
  • Currently enrolled in an ophthalmic clinical trial
  • Strabismus
  • Any use of medications for which contact lens wear could be contraindicated as determined by the investigator
  • Other protocol exclusion criteria may apply

About this study

The purpose of this trial is to compare the performance of two contact lenses for contact lens wearers with astigmatism.

Conditions
Astigmatism, Myopia
Being tested
Nelfilcon A investigational contact lens, Nelfilcon A commercial contact lens
Medical subject headings
Astigmatism, Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nelfilcon A investigational contact lensDevice

    Investigational, soft contact lens for astigmatism worn on a daily disposable basis.

  • Nelfilcon A commercial contact lensDevice

    Also called Focus DAILIES Toric

    Commercially marketed, soft contact lens for astigmatism worn on a daily disposable basis.

Study groups in NCT01207466
Study groupRoleWhat they receive
Nelfilcon A invest'l / nelfilconA comm'lOtherNelfilcon A investigational toric contact lenses worn first, with nelfilcon A commercial toric contact lenses worn second. Each product worn bilaterally on a daily disposable basis for one week.
Receives: Device: Nelfilcon A investigational contact lens; Device: Nelfilcon A commercial contact lens
Nelfilcon A comm'l / nelfilconA invest'lOtherNelfilcon A commercial toric contact lenses worn first, with nelfilcon A investigational toric contact lenses worn second. Each product worn bilaterally on a daily disposable basis for one week.
Receives: Device: Nelfilcon A investigational contact lens; Device: Nelfilcon A commercial contact lens

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of Vision (Crisp and Clear)

    Quality of vision (crisp and clear), as interpreted and reported by the participant by eye on a questionnaire as a single, retrospective evaluation of one week's wear time. Quality of vision was assessed on a 10-point scale, with 1 being poor and 10 being excellent.

    Measured: 1 week of wear

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2010 (estimated)
  2. Study startSep 2010
  3. Primary completionOct 2010
  4. Study completionOct 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
95 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01207466
Sponsor's protocol ID
P-415-C-001 sub 2
Status last verified
Jan 2012
First submitted
21 Sep 2010
Last updated
10 Jul 2012
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Nelfilcon A investigational contact lens and Nelfilcon A commercial contact lens in people with Astigmatism and Myopia, run by CIBA VISION.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jul 2012. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Aug 2011). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of Vision (Crisp and Clear) (time frame: 1 week of wear). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in